| Serum pro‐inflammatory and anti‐inflammatory cytokines and the pathogenesis of experimental autoimmune encephalomyelitis AJ Jahan‐Abad, S Karima, S Shateri, SM Baram, S Rajaei, ... Neuropathology 40 (1), 84-92, 2020 | 27 | 2020 |
| Peroxisome proliferator-activated receptor-α inhibition protects against doxorubicin-induced cardiotoxicity in mice M Rahmatollahi, SM Baram, R Rahimian, SS Saeedi Saravi, AR Dehpour Cardiovascular toxicology 16, 244-250, 2016 | 23 | 2016 |
| Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo … SM Baram, S Karima, S Shateri, A Tafakhori, A Fotouhi, BS Lima, S Rajaei, ... Inflammopharmacology 27, 1101-1112, 2019 | 21 | 2019 |
| Conformational change and GTPase activity of human tubulin: a comparative study on Alzheimer’s disease and healthy brain S Rajaei, S Karima, H Sepasi Tehrani, S Shateri, S Mahmoodi Baram, ... Journal of Neurochemistry 155 (2), 207-224, 2020 | 9 | 2020 |
| Acetyl-11-Keto-Beta-Boswellic Acid Has Therapeutic Benefits for NAFLD Rat Models That Were Given a High Fructose Diet by Ameliorating Hepatic Inflammation and Lipid Metabolism RA Kachouei, A Doagoo, M Jalilzadeh, SH Khatami, S Rajaei, ... Inflammation 46 (5), 1966-1980, 2023 | 2 | 2023 |
| Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease S Karima, V Aghamollaii, S Mahmoodi Baram, L Balenci, KL Lanctôt, ... Journal of Alzheimer's Disease, 1-12, 2023 | 2 | 2023 |
| Boswellia serrata extract shows cognitive benefits in a double-blind, randomized, placebo-controlled pilot clinical trial in individuals who suffered traumatic brain injury S Meshkat, S Mahmoodi Baram, S Rajaei, F Mohammadian, ... Brain Injury 36 (4), 553-559, 2022 | 2 | 2022 |
| Plasma cytokines profile in patients with Alzheimer’s and Parkinson’s Disease: a comparative study in terms of inflammation S Shateri, SH Khatami, A Haghbin Toutounchi, S Rajaei, M Mahdavi, ... International Journal of Neuroscience, 1-10, 2023 | 1 | 2023 |
| Plasma cytokines profile in subjects with Alzheimer’s disease: interleukin 1 alpha as a candidate for target therapy M Mahdavi, S Karima, S Rajaei, V Aghamolaii, H Ghahremani, R Ataei, ... Galen Medical Journal 10, e1974, 2021 | 1 | 2021 |
| Increased Salivary Nitrite and Nitrate Excretion in Rats with Cirrhosis S Mahmoodi, M Rahmatollahi, F Shahsavari, H Shafaroodi, ... Acta Medica Iranica, 669-675, 2015 | 1 | 2015 |
| Boswellic acids (K‐Vie™) improves clinical cognitive scores and reduces systemic inflammation in patients with mild to moderate Alzheimer’s disease. S Karima, V Aghamollaii, A Tafakhori, SM Baram, L Balenci, KL Lanctôt, ... Alzheimer's & Dementia 18, e063660, 2022 | | 2022 |
Ahmad R. DehpourDistinguished Professor of Pharmacology, Tehran University of Medical SciencesVerified email at sina.tums.ac.ir
